欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗
Item Cat. No. Application Isotype
Anti-Respiratory Syncytial Virus Glycoprotein F mAbs [Palivizumab Biosimilar] (MABL-5060) MABL-5060 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-VEGF mAbs [Palverafusp Biosimilar] (MABL-5061) MABL-5061 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-TNFRSF17/CD269/BCMA/TNFRSF13A;CD3E mAbs [Pamlectabart Biosimilar] (MABL-5062) MABL-5062 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-PDL1/CD274;TNFRSF9/CD137/4-1BB mAbs [Opamistomig Biosimilar] (MABL-5034) MABL-5034 ELISA, FACS, Functional assay, in vivo binding G1;na, Kappa;Lambda
Anti-KIT/CD117 mAbs [Opelkibart Biosimilar] (MABL-5035) MABL-5035 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-LINGO1 mAbs [Opicinumab Biosimilar] (MABL-5036) MABL-5036 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-EPCAM/CD326 mAbs [Oportuzumab Biosimilar] (MABL-5037) MABL-5037 ELISA, FACS, Functional assay, in vivo binding na, Kappa
Anti-PDL1/CD274 mAbs [Opucolimab Biosimilar] (MABL-5038) MABL-5038 ELISA, FACS, Functional assay, in vivo binding G1, Lambda
Anti-FOLR1;FOLR1 mAbs [Opugotamig Biosimilar] (MABL-5039) MABL-5039 ELISA, FACS, Functional assay, in vivo binding G1;G1, Kappa;Kappa
Anti-IL15 mAbs [Ordesekimab Biosimilar] (MABL-5040) MABL-5040 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-FCGRT/FcRn mAbs [Orilanolimab Biosimilar] (MABL-5041) MABL-5041 ELISA, FACS, Functional assay, in vivo binding G4, Kappa
Anti-Rabies Virus Surface Glycoprotein 4 (gp4) Epitope 1 mAbs [Ormutivimab Biosimilar] (MABL-5042) MABL-5042 ELISA, FACS, Functional assay, in vivo binding G1, Lambda
Anti-OxLDL mAbs [Orticumab Biosimilar] (MABL-5043) MABL-5043 ELISA, FACS, Functional assay, in vivo binding G1, Lambda
Anti-CLDN18 mAbs [Osemitamab Biosimilar] (MABL-5044) MABL-5044 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-F11 mAbs [Osocimab Biosimilar] (MABL-5045) MABL-5045 ELISA, FACS, Functional assay, in vivo binding G1, Kappa
Anti-CD3E mAbs [Otelixizumab Biosimilar] (MABL-5046) MABL-5046 ELISA, FACS, Functional assay, in vivo binding G1, Lambda
Anti-KDR/CD309/VEGFR2 mAbs [Olinvacimab Biosimilar] (MABL-5018) MABL-5018 ELISA, FACS, Functional assay, in vivo binding G1, Lambda
Anti-LGALS3/GAL3 mAbs [Oloctinebart Biosimilar] (MABL-5019) MABL-5019 ELISA, FACS, Functional assay, in vivo binding G4, Kappa
Anti-IL6 mAbs [Olokizumab Biosimilar] (MABL-5020) MABL-5020 ELISA, FACS, Functional assay, in vivo binding G4, Kappa
Anti-IGHE mAbs [Omalizumab Biosimilar] (MABL-5021) MABL-5021 ELISA, FACS, Functional assay, in vivo binding G1, Kappa

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号